KEGG   PATHWAY: ppam05213
Entry
ppam05213                   Pathway                                
Name
Endometrial cancer - Pteronotus mesoamericanus (Parnell's mustached bat)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
ppam05213  Endometrial cancer
ppam05213

Disease
H00026  Endometrial cancer
Organism
Pteronotus mesoamericanus (Parnell's mustached bat) [GN:ppam]
Gene
129062984  BRAF; serine/threonine-protein kinase B-raf isoform X1 [KO:K04365] [EC:2.7.11.1]
129063946  NRAS; GTPase NRas [KO:K07828]
129064134  [KO:K03099]
129064157  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
129065223  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
129065226  ELK1; ETS domain-containing protein Elk-1 [KO:K04375]
129066034  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
129066231  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
129066646  CTNNA1; catenin alpha-1 [KO:K05691]
129066685  TCF7; transcription factor 7 isoform X1 [KO:K02620]
129066993  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
129067419  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
129067686  FOXO3; forkhead box protein O3 [KO:K09408]
129068523  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
129068612  BAD; bcl2-associated agonist of cell death [KO:K02158]
129068919  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
129069407  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X1 [KO:K02649]
129069640  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
129069750  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
129069921  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
129069949  CTNNA3; catenin alpha-3 [KO:K05691]
129070231  AXIN2; axin-2 isoform X1 [KO:K04385]
129072290  TP53; cellular tumor antigen p53 [KO:K04451]
129073033  AKT3; RAC-gamma serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
129073113  HRAS; GTPase HRas isoform X1 [KO:K02833]
129073940  CTNNA2; catenin alpha-2 isoform X1 [KO:K05691]
129073949  TCF7L1; transcription factor 7-like 1 [KO:K04490]
129074590  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
129074622  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
129074969  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
129075248  CDH1; cadherin-1 [KO:K05689]
129075586  CASP9; caspase-9 [KO:K04399] [EC:3.4.22.62]
129075675  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
129076407  ILK; integrin-linked protein kinase [KO:K06272] [EC:2.7.11.1]
129076577  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
129076641  AKT2; RAC-beta serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
129077183  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
129078069  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
129078155  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
129081112  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
129081256  AXIN1; axin-1 isoform X1 [KO:K02157]
129081434  DDB2; DNA damage-binding protein 2 [KO:K10140]
129081677  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
129082291  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
129082924  BAX; apoptosis regulator BAX [KO:K02159]
129083615  PDPK1; 3-phosphoinositide-dependent protein kinase 1 isoform X1 [KO:K06276] [EC:2.7.11.1]
129083908  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
129084081  MYC; myc proto-oncogene protein [KO:K04377]
129084969  KRAS; GTPase KRas isoform X1 [KO:K07827]
129085287  EGF; pro-epidermal growth factor isoform X1 [KO:K04357]
129085299  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
129086248  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
129086587  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
129087036  ERBB2; receptor tyrosine-protein kinase erbB-2 [KO:K05083] [EC:2.7.10.1]
129087856  MLH1; DNA mismatch repair protein Mlh1 [KO:K08734]
129088214  CTNNB1; catenin beta-1 isoform X1 [KO:K02105]
129088291  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform [KO:K00922] [EC:2.7.1.153]
129088423  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
ppam04010  MAPK signaling pathway
ppam04012  ErbB signaling pathway
ppam04060  Cytokine-cytokine receptor interaction
ppam04110  Cell cycle
ppam04115  p53 signaling pathway
ppam04151  PI3K-Akt signaling pathway
ppam04310  Wnt signaling pathway
ppam04520  Adherens junction
KO pathway
ko05213   

DBGET integrated database retrieval system